Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-29 Purchase |
2022-05-03 5:49 pm |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner |
2,118,644 | $2.36 | $5,000,000 | 4,295,055 (Indirect) |
View |
| 2022-01-07 Purchase |
2022-01-11 6:36 pm |
Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President |
2,000 | $4.78 | $9,560 | 113,343 (Direct) |
View |
| 2022-01-06 Purchase |
2022-01-10 6:37 pm |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
1,700 | $4.8048 | $8,168 | 1,901 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-17 Option Award |
2022-06-22 4:09 pm |
N/A 2032-06-16 |
Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director |
3,500 | $0 | 3,500 (Direct) |
View |
Ownership |
2022-05-03 5:07 pm |
N/A N/A |
Tempest Therapeutics Inc. | TPST | Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
0 | $0 | 2,118,644 (Direct) |
View |
Ownership |
2022-01-10 5:15 pm |
N/A N/A |
Tempest Therapeutics Inc. | TPST | Rock Springs Capital Management LP Rock Springs Capital LLC Rock Springs Capital Master Fund LP 10% Owner |
0 | $0 | 823,654 (Indirect) |
View |
| 2022-01-04 Option Award |
2022-01-06 7:26 pm |
N/A 2032-01-03 |
Tempest Therapeutics Inc. | TPST | Lorenzo Pierre Corporate Controller |
6,500 | $0 | 6,500 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 7:26 pm |
N/A 2032-01-03 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance |
19,500 | $0 | 19,500 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 7:25 pm |
N/A 2032-01-03 |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
29,000 | $0 | 29,000 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 7:23 pm |
N/A 2032-01-03 |
Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer |
94,500 | $0 | 94,500 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 7:22 pm |
N/A 2032-01-03 |
Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President |
53,100 | $0 | 53,100 (Direct) |
View |
| 2021-09-21 Option Award |
2021-09-23 7:56 pm |
N/A 2031-09-20 |
Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award(A) |
2021-09-20 8:34 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award(A) |
2021-09-20 8:29 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award(A) |
2021-09-20 8:13 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award(A) |
2021-09-20 8:10 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Xu Stella Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-08-06 Option Award |
2021-08-10 7:05 pm |
N/A 2031-08-05 |
Tempest Therapeutics Inc. | TPST | Simantov Ronit Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-12 Option Award |
2021-07-14 4:27 pm |
N/A 2031-07-11 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance |
23,225 | $0 | 23,225 (Direct) |
View |
Ownership |
2021-07-06 6:26 pm |
N/A N/A |
Tempest Therapeutics Inc. | TPST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Venture Capital IV L.P. Versant Ventures IV LLC Versant Side Fund IV L.P. 10% Owner |
0 | $0 | 2,176,411 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 6:05 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Xu Stella Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 6:01 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:56 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:52 pm |
N/A 2031-06-30 |
Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director |
6,635 | $0 | 6,635 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-30 4:16 pm |
N/A 2030-11-15 |
Millendo Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
605,395 | $0 | 605,395 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 9:56 pm |
N/A N/A |
Millendo Therapeutics Inc. | TPST | Xu Stella Director |
579,710 | $0 | 579,710 (Indirect) |
View |
| 2021-06-25 Option Award |
2021-06-29 9:55 pm |
N/A 2028-10-02 |
Millendo Therapeutics Inc. | TPST | Dubensky Thomas W. President |
1,201,644 | $0 | 1,201,644 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 9:55 pm |
N/A 2028-12-18 |
Millendo Therapeutics Inc. | TPST | RAAB MICHAEL Director |
31,274 | $0 | 31,274 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 9:54 pm |
N/A 2029-09-15 |
Millendo Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer |
2,170,988 | $0 | 2,170,988 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 9:54 pm |
N/A N/A |
Millendo Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner |
2,176,411 | $0 | 7,377 (Indirect) |
View |
| 2021-06-25 Option Award |
2021-06-29 9:53 pm |
N/A 2030-11-15 |
Millendo Therapeutics Inc. | TPST | Lorenzo Pierre Corporate Controller |
54,652 | $0 | 54,652 (Direct) |
View |